Table 3.
Analysis of mutations in the predicted F protein antigenic domains structure between LaSota vaccine and our AOAvV-1 isolates reported in this study.
| Domain | Antigenic Region I (7–30) |
Antigenic Region II (196–241) | Antigenic Region III (380–394) | Antigenic Region IV (413–437) | Antigenic Region V (447–460) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A.A positions | 8 | 9 | 13 | 16 | 17 | 19 | 20 | 22 | 27 | 28 | 29 | 30 | 203 | 231 | 232 | 385 | 386 | 387 | 421 | 422 | 430 | 451 | 457 |
| LaSota (JF950510.1) | K | N | M | T | I | V | A | V | C | P | A | N | A | N | K | T | I | K | K | Q | G | Q | I |
| AOAvV-1 isolates | R | I | L | I | T | I | M | I | R | L | T | S | T | T | Q | A | L | R | R | H | D | L | V |